Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw

Phase 1CompletedNCT01834612

Zynex Monitoring Solutions20 enrolled

Overview

To determine if a manual blood loss can be detected using the non-invasive blood monitor.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Blood Loss

Interventions

CM1500DEVICE

blood volume monitor

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * healthy volunteer * between 18 to 50 years of age * weight between 157 to 220 lbs Exclusion Criteria: * unstable or untreated cardia disease * alcohol consumption in 24 hours prior to screening * tobacco use in 4 hours prior to screening * pregnancy * infection * Hemoglobin \< 12.5 g/dL at time of procedure

Locations (1)

DaVita Clinical Research

Lakewood, Colorado, United States

Outcomes

Primary Outcomes

Detect change in blood volume by non-invasive monitoring during whole blood draw

Time frame: 4 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.